SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jackson, J. D.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Outcomes Research: Issues of Evidence, Timing and Application

Joseph D. Jackson

We have entered the era of value for money, and it will likely last into the next century. Increasingly, the use of pharmaceuticals will be a function of the value for money they bring to specific populations at risk. As an integral part of this era, the outcomes research movement is pursuing the quest for value; however, the movement is in its infancy. There is a great appetite for systematic outcomes research that would assess unmet clinical need, the novelty of the clinically meaningful outcomes, and the potential for monetary benefit. The basic premise of outcomes research is that choices between alternatives must be made to promote efficiency without compromising quality of care. Although choices must be made, the foundation for these decisions is properly good research evidence. The process of evidence generation is time-intensive, especially in diseases with long episodes of illness. Therefore, it will take time to produce clinically meaningful data on factors such as mortality and morbidity gains, health-related quality of life, productivity enhancements, patient and provider satisfaction and compliance, especially for new drugs. The needs are acute and the promise is great, but the movement is probably more evolutionary than revolutionary. Copyright © 1995 by W.B. Saunders Company

Journal of Pharmacy Practice, Vol. 8, No. 4, 178-184 (1995)
DOI: 10.1177/089719009500800406


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement